Synergistic Effect of Tangeretin and Atorvastatin for Colon Cancer Combination Therapy: Targeted Delivery of These Dual Drugs Using RGD Peptide Decorated Nanocarriers

PURPOSE: Colorectal cancer (CRC) is the third most frequently diagnosed cancer and the fourth leading cause of cancer death over the world. Nano-sized drug delivery systems are used for the treatment of cancers. The aim of this study was to develop a tangeretin (TAGE) and atorvastatin (ATST) combine...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, He, Zheng, Nanbo, Li, Zhuanting, Zhi, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397562/
https://www.ncbi.nlm.nih.gov/pubmed/32801644
http://dx.doi.org/10.2147/DDDT.S256636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397562/
https://www.ncbi.nlm.nih.gov/pubmed/32801644
http://dx.doi.org/10.2147/DDDT.S256636

Ejemplares similares